Nirmala Sitharaman, Kiran Shaw among Forbes’s most powerful women

Nirmala Sitharaman

Chennai: Finance Minister Nirmala Sitharaman, US Vice President-elect Kamala Harris, Biocon Founder Kiran Mazumdar-Shaw and HCL Enterprise CEO Roshni Nadar Malhotra have been named among the world’s 100 most powerful women by Forbes, a list topped by German Chancellor Angela Merkel for the 10th year in a row.

The women on the 17th annual Forbes Power List hail from 30 countries and were born across four generations.

There are 10 heads of State, 38 CEOs and five entertainers among them. But where they differ in age, nationality and job description, they are united in the ways they have been using their platforms to address the unique challenges of 2020, Forbes said.

Sitharaman is ranked 41st on the list, Nadar Malhotra comes in at the 55th spot, Mazumdar-Shaw—described as India’s richest self-made woman—is ranked 68th and chairwoman of Landmark Group Renuka Jagtiani is ranked 98th. Merkel ranks number one for the tenth year in a row.

Kiran Mazumdar-Shaw

Harris, who became the first woman, first Black American and first Asian American to be elected vice president – “an unprecedented trifecta of firsts for California Senator Harris,” is ranked third on the list.

European Central Bank chief Christine Lagarde is ranked second for the second straight year.

From fighting the pandemic to re-engineering American politics, these influential women, including New Zealand Prime Minister Jacinda Ardern, Vice President-elect Kamala Harris and voting rights advocate Stacey Abrams, are making history, Forbes said.

There are 17 newcomers on this year’s list, illustrating that women are leading all aspects of a society transformed by a global pandemic.

New CEO of American multinational company United Parcel Service Carol Tom (No. 11) and head of California-based Clorox Linda Rendle (No. 87) are responsible for helping provide essential services that have kept Americans connected and clean.

CVS Health executive vice-president and incoming CEO Karen Lynch (No. 38) leads the pharmacy giant’s vast Covid-19 testing programme and, in 2021 will be responsible for its critical handling of coronavirus vaccines.


NT Bureau